These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15703904)

  • 21. Capacity building and stroke risk assessment in Nigerian children with sickle cell anaemia.
    Soyebi K; Adeyemo T; Ojewunmi O; James F; Adefalujo K; Akinyanju O
    Pediatr Blood Cancer; 2014 Dec; 61(12):2263-6. PubMed ID: 25174615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study.
    Adams RJ; Brambilla DJ; Granger S; Gallagher D; Vichinsky E; Abboud MR; Pegelow CH; Woods G; Rohde EM; Nichols FT; Jones A; Luden JP; Bowman L; Hagner S; Morales KH; Roach ES;
    Blood; 2004 May; 103(10):3689-94. PubMed ID: 14751925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with sickle cell disease are frequently excluded from the benefits of transcranial doppler screening for the risk of stroke despite extensive and compelling evidence.
    Rodrigues DL; Adegoke SA; Campos RS; Braga JA; Figueiredo MS; Silva GS
    Arq Neuropsiquiatr; 2017 Jan; 75(1):15-19. PubMed ID: 28099557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study.
    Adams RJ
    J Child Neurol; 2000 May; 15(5):344-9. PubMed ID: 10830201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium.
    Schlenz AM; Phillips S; Mueller M; Melvin C; Adams RJ; Kanter J;
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28172. PubMed ID: 31925913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening of cerebral vasculopathy in sickle cell anemia children using transcranial Doppler].
    Dorie A; Guindo A; Saro YS; Touré BA; Fané B; Dembelé AK; Diallo DA
    Arch Pediatr; 2015 Mar; 22(3):260-6. PubMed ID: 25636211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
    Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
    Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
    Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
    PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
    Rankine-Mullings A; Reid M; Soares D; Taylor-Bryan C; Wisdom-Phipps M; Aldred K; Latham T; Schultz WH; Knight-Madden J; Badaloo A; Lane A; Adams RJ; Ware RE
    Br J Haematol; 2021 Nov; 195(4):612-620. PubMed ID: 34291449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DISPLACE study shows poor quality of transcranial doppler ultrasound for stroke risk screening in sickle cell anemia.
    Davidow KA; Miller RE; Phillips SM; Schlenz AM; Mueller M; Hulbert ML; Hsu LL; Bhasin N; Adams RJ; Kanter J
    Blood Adv; 2024 Jul; 8(13):3444-3452. PubMed ID: 38669350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification.
    Padayachee ST; Thomas N; Arnold AJ; Inusa B
    Pediatr Radiol; 2012 Apr; 42(4):470-4. PubMed ID: 22002844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrovascular complications in children with sickle cell disease.
    De Montalembert M; Wang W
    Handb Clin Neurol; 2013; 113():1937-43. PubMed ID: 23622417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease.
    Brambilla DJ; Miller ST; Adams RJ
    Pediatr Blood Cancer; 2007 Sep; 49(3):318-22. PubMed ID: 17243135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.
    Zimmerman SA; Schultz WH; Burgett S; Mortier NA; Ware RE
    Blood; 2007 Aug; 110(3):1043-7. PubMed ID: 17429008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
    Lagunju I; Brown BJ; Sodeinde O
    Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angle-corrected imaging transcranial doppler sonography versus imaging and nonimaging transcranial doppler sonography in children with sickle cell disease.
    Krejza J; Rudzinski W; Pawlak MA; Tomaszewski M; Ichord R; Kwiatkowski J; Gor D; Melhem ER
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1613-8. PubMed ID: 17846223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
    Lagunju I; Brown BJ; Oyinlade AO; Asinobi A; Ibeh J; Esione A; Sodeinde OO
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27252. PubMed ID: 29797633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.